BOUL.ST

Healthcare Medical Devices

Boule Diagnostics AB (publ)

SEK 2.27

-0.07 -2.99% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 3:00 PM ET	2.27

Key Stats

Market Cap

88.15M

Avg Volume

38,535

EPS

-SEK 0.10

52W High

SEK 6.64

52W Low

SEK 2.21

Div. Yield

0.0%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

2.01

P/B Ratio

0.50

P/S Ratio

0.19

EV/EBITDA

13.79

EV/Revenue

0.65

Margins

Gross Margin 43.0%

Operating Margin 2.9%

Net Margin (0.6%)

EBITDA Margin 4.7%

Growth & Returns

Revenue Growth (YoY)

(13.2%)

Return on Equity

(1.6%)

Return on Assets

3.5%

Liquidity & Leverage

Current Ratio

1.07

Quick Ratio

0.68

Debt / Equity

1.30

Total Cash

19.60M

Total Debt

227.30M

About

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. It operates through Diagnostics and OEM Clinical Diagnostic Solutions. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.